Goossens L - Search Results

1

Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor.

Millet R, Goossens L, Goossens JF, Chavatte P, Bertrand-Caumont K, Houssin R, Hénichart JP. Millet R, et al. Among authors: goossens jf, goossens l. J Pept Sci. 2001 Jun;7(6):323-30. doi: 10.1002/psc.326. J Pept Sci. 2001. PMID: 11461046

2

A flexible approach to the design of new potent substance P receptor ligands.

Millet R, Goossens L, Bertrand-Caumont K, Goossens JF, Houssin R, Hénichart JP. Millet R, et al. Among authors: goossens jf, goossens l. J Pharm Pharmacol. 2001 Jul;53(7):929-34. doi: 10.1211/0022357011776324. J Pharm Pharmacol. 2001. PMID: 11480541

3

Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor.

Barbey S, Goossens L, Taverne T, Cornet J, Choesmel V, Rouaud C, Gimeno G, Yannic-Arnoult S, Michaux C, Charlier C, Houssin R, Hénichart JP. Barbey S, et al. Among authors: goossens l. Bioorg Med Chem Lett. 2002 Mar 11;12(5):779-82. doi: 10.1016/s0960-894x(02)00013-6. Bioorg Med Chem Lett. 2002. PMID: 11859001

4

Novel potent substance P and neurokinin A receptor antagonists. Conception, synthesis and biological evaluation of indolizine derivatives.

Millet R, Domarkas J, Rigo B, Goossens L, Goossens JF, Houssin R, Hénichart JP. Millet R, et al. Among authors: goossens jf, goossens l. Bioorg Med Chem. 2002 Sep;10(9):2905-12. doi: 10.1016/s0968-0896(02)00144-x. Bioorg Med Chem. 2002. PMID: 12110311

5

Discovery of orally bioavailable NK1 receptor antagonists.

Genicot C, Christophe B, Collart P, Gillard M, Goossens L, Hénichart JP, Lassoie MA, Moureau F, Neuwels M, Nicolas JM, Pasau P, Quéré L, Ryckmans T, Stiernet F, Taverne T, Van Keulen BJ. Genicot C, et al. Among authors: goossens l. Bioorg Med Chem Lett. 2003 Feb 10;13(3):437-42. doi: 10.1016/s0960-894x(02)00956-3. Bioorg Med Chem Lett. 2003. PMID: 12565946

6

1-[4-(Methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole derivatives.

Charlier C, Norberg B, Goossens L, Hénichart JP, Durant F. Charlier C, et al. Among authors: goossens l. Acta Crystallogr C. 2004 Sep;60(Pt 9):o648-52. doi: 10.1107/S0108270104016117. Epub 2004 Aug 11. Acta Crystallogr C. 2004. PMID: 15345845

7

New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.

Pommery N, Taverne T, Telliez A, Goossens L, Charlier C, Pommery J, Goossens JF, Houssin R, Durant F, Hénichart JP. Pommery N, et al. Among authors: goossens jf, goossens l. J Med Chem. 2004 Dec 2;47(25):6195-206. doi: 10.1021/jm0407761. J Med Chem. 2004. PMID: 15566290

8

Spectroscopic study of fluorescent peptides for prenyl transferase assays.

Goossens L, Deweer S, Pommery J, Hénichart JP, Goossens JF. Goossens L, et al. Among authors: goossens jf. J Pharm Biomed Anal. 2005 Mar 9;37(3):417-22. doi: 10.1016/j.jpba.2004.11.006. Epub 2004 Dec 10. J Pharm Biomed Anal. 2005. PMID: 15740898

9

Antiproliferative effects of isopentenylated coumarins isolated from Phellolophium madagascariense Baker.

Riviere C, Goossens L, Pommery N, Fourneau C, Delelis A, Henichart JP. Riviere C, et al. Among authors: goossens l. Nat Prod Res. 2006 Aug;20(10):909-16. doi: 10.1080/14786410500277787. Nat Prod Res. 2006. PMID: 16854718

10

COX-2/5-LOX dual acting anti-inflammatory drugs in cancer chemotherapy.

Goossens L, Pommery N, Hénichart JP. Goossens L, et al. Curr Top Med Chem. 2007;7(3):283-96. doi: 10.2174/156802607779941369. Curr Top Med Chem. 2007. PMID: 17305571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters